A
Alessandra Ruggeri
Researcher at University of Bologna
Publications - 68
Citations - 3757
Alessandra Ruggeri is an academic researcher from University of Bologna. The author has contributed to research in topics: Dentin & Osseointegration. The author has an hindex of 24, co-authored 68 publications receiving 3522 citations.
Papers
More filters
Journal ArticleDOI
Dental adhesion review: Aging and stability of the bonded interface
Lorenzo Breschi,Annalisa Mazzoni,Alessandra Ruggeri,Milena Cadenaro,Roberto Di Lenarda,E. Dorigo +5 more
TL;DR: This study critically discusses the latest peer-reviewed reports related to formation, aging and stability of resin bonding, focusing on the micro and nano-phenomena related to adhesive interface degradation.
Journal ArticleDOI
Collagen structure and functional implications.
TL;DR: The relationship between the inner structure of collagen fibrils, their diameter, their spatial layout and the functional requirements they have to withstand are discussed, and it is suggested that collagenfibrils may belong to two different forms indicated as "T-type" and "C-type".
Journal ArticleDOI
Chlorhexidine stabilizes the adhesive interface: a 2-year in vitro study.
Lorenzo Breschi,Annalisa Mazzoni,F Nato,Marcela Carrilho,Marcela Carrilho,E Visintini,Leo Tjäderhane,Alessandra Ruggeri,Franklin Chi Meng Tay,E. Dorigo,David H. Pashley +10 more
TL;DR: The study demonstrates the active role of SB1XT in dentin MMP-2 activation and the efficacy of CHX inhibition of MMPs even if used at low concentration (0.2%).
Journal ArticleDOI
Hierarchical structures in fibrillar collagens.
TL;DR: It is now indisputable that collagen interacts and forms functional entities with several other macromolecules of the extracellual matrix, as their structure and their functional role become known.
Journal ArticleDOI
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Am Martelli,P. L. Tazzari,Giovanna Tabellini,Roberta Bortul,A. M. Billi,Lucia Manzoli,Alessandra Ruggeri,Roberto Conte,Lucio Cocco +8 more
TL;DR: Testing whether or not a new selective Akt inhibitor was as effective as Ly294002 in lowering the sensitivity threshold of HL60 cells to chemotherapeutic drugs, TRAIL, ATRA, and ionizing radiation indicates that selective AkT pharmacological inhibitors might be used in the future for enhancing the sensitivity of leukemia cells to therapeutic treatments that induce apoptosis or for overcoming resistance to these treatments.